期刊文献+

载γ-球蛋白微包纳载体的制备与性能 被引量:1

Preparation and characterization of NEMs loading γ-globulin
下载PDF
导出
摘要 为了结合不同载体的特点从而实现更佳的性能,载体的集成化研究已日益成为研究者关注的热点。为了延长微胶囊的释放时间,构筑了新型的微包纳载体形式并用于大分子药物γ-球蛋白的包埋及释放。所制备的微包纳胶囊表面光洁,球形度较好,胶囊之间无粘连,分散性较好,粒度分布均匀。几丁聚糖分子量、浓度及药物初始浓度对载药量及体外释放影响不一。与单纯微胶囊相比,微包纳胶囊能够显著延长药物的释放时间,从而为该新型载体在大分子药物释放的应用方面提供了实验依据。 To combine the characteristics of different carriers for better properties, carrier combination has been a hot field in recent years. In this article, a novel nanoparticles embedded microcapsules (NEMs) was constructed for the encapsulation and release of macromolecular drug γ-globulin to extend the release period of microcapsules. The prepared NEMs showed smooth surface, good sphericity and dispersity. The capsules had no adhesion and were well distributed. The drug initial concentration, chitosan molecular weight and concentration on drug loading and release in vitro were investigated. Compared with microcapsules, NEMs could extend the release period obviously, and it would supply experimental data in the future application of NEMs in macromo lecular drug release.
出处 《功能材料》 EI CAS CSCD 北大核心 2013年第8期1212-1216,共5页 Journal of Functional Materials
基金 国家自然科学基金资助项目(31000441 31170939) 福建省自然科学基金资助项目(2011J01223) 中央高校基本科研业务费资助项目(JB-JC1009 JB-SJ1009) 教育部回国人员科研启动基金对本项目的资助
关键词 微包纳 γ-球蛋白 载药量 缓释 nanoparticles embedded microcapsules γ-globulin drug loading sustained release
  • 相关文献

参考文献22

  • 1Teow H M, Zhou Z, Najlah M, et al. Delivery of paclita- xel across cellular barriers using a dendrimer based nano- carrier [J]. International Journal of Pharmaceutics, 2013, 441: 701-711.
  • 2Prakash S, Malhotra M, Shao W, et al. Polymeric nano- hybrids and functionalized carbon nanotubes as drug deliv- ery carriers for cancer therapy [J]. Advanced Drug Deliv- ery Reviews, 2011, 63: 1340-1351.
  • 3Nampi P P, Mohan V S,Sinha A K, et al. High surface area sol-gel nano silica as a novel drug carrier substrate for sustained drug release [J]. Materials Research Bulle- tin, 2012, 47: 1379-1384.
  • 4Xu Z, Ji Y, Guan M, et al. Preparation and eharaeteriza tion of L-Leucine modified amphiprotic bifunctional meso porous SBA-15 molecular sieve as a drug carrier for riba virin [J]. Applied Surface Science, 2010, 256: 3160 3165.
  • 5Betz M,Garcia-Gonzdlez C A, Subrahmanyam R P. Prep aration of novel whey protein-based aerogels as drug carri ers for life science applications [J]. The Journal of Super critical Fluids, 2012, 72: 111-119.
  • 6Janaswamy S, Gill K L, Campanella O H, et al. Organ ized polysaccharide fibers as stable drug carriers [J]. Car bohydrate Polymers, 2013, doi: 10. 1016/j. carbpol. 2013 01. 008.
  • 7Liu G, Fan W, Li L, et al. Novel anionic fluorine-contai- ning amphiphilic selassembly polymer micelles for po- tential application in protein drug carrier [J]. Journal of Fluorine Chemistry, 2012, 141: 21-28.
  • 8Jiang H, Wang T, Wang L, et al. Development of an amorphous mesoporous TiO2 nanosphere as a novel carri- er for poorly water-soluble drugs: Effect of different crys- tal forms of TiO2 carriers on drug loading and release be- haviors [J]. Microporous and Mesoporous Materials, 2012, 153: 124-130.
  • 9Lu J, Huang Y, Zhao W, et al. PEG-derivatized embelin as a nanomicellar carrier for delivery of paclitaxel to breast and prostate cancers [J]. Biomaterials, 2013, 34: 1591-1600.
  • 10Mohanray V J, Barnes T J, Prestidge C A. Silica nano particle coated liposomes: a new type of hybrid nanocap sule for proteins [J]. International Journal of Pharma ceutics, 2010, 392: 285-293.

二级参考文献52

共引文献35

同被引文献14

  • 1冯玉红,现代仪器分析使用教程[M].北京:北京大学出版社,2008.
  • 2Gopferich A, Alonso M J, Langer R, et al. Development and characterization of microencapsulation microspheres[J]. Pharm Res, 1994,11(11) : 1568.
  • 3Liu Y, Sun X, Wang S, et al. Preparation of nanoparticles embedded microcapsules (NEMs) and their application in drug release[J]. Mater Lett, 2012,75: 48.
  • 4Lee P B, Bidard F C, Pierga J Y. Contemporary issues and the potential uses of capecitabine in metastatic breast cancer[J]. Cancer Treatment Rev, 2009,35 (7) : 582.
  • 5Kosuri K V, Wu X, Wang L, et aL An epigenetie meeha nism for capecitabine resistance in mesothelioma[J]. Bio- chem Biophys Res Commun, 2010,391 (3) : 1465.
  • 6Wang J, Fan Y, Xu B. Ixabepilone plus capecitabine for Chinese patients with metastatic breast cancer progressing after anthracycline and taxane treatment[J]. Cancer Che moth Pharm, 2010,66(3) : 597.
  • 7Izzedine H, Massard C, Spano J P, et al. VEGF signalling inhibition-induced proteinuria: Mechanisms, significance and management[J]. Eur J Cancer,2010,46(2) :439.
  • 8Degirmenci M, et al. Efficacy and safety of bevacizumab plus eapecitabine and irinotecan regimen for metastatic colo rectal cancer[J]. Med Oncol,2009,27(3):585.
  • 9吴建锋,於得红,方超,贾连顺,李家顺,许国华.甲氨蝶呤-聚乳酸-羟基乙酸共聚物纳米囊的制备及其体外释药的研究[J].中国药学杂志,2010,45(2):119-123. 被引量:8
  • 10顾阳春,马力文.VEGF/VEGFR与胃癌[J].癌症进展,2010,8(1):71-74. 被引量:9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部